SINGAPORE (June 13): Cord blood bank operator Cordlife Group on Monday announced the appointment of Dr Wong Chiang Yin as Group CEO and Executive Director with effect from July 1.

Dr Wong is a medical doctor and a public health specialist with more than 20 years of healthcare management experience.

“I am honored to be given the mandate to bring the Group to its next level of growth, building on a strong foundation. The regional healthcare market offers many opportunities and I believe it is important to leverage on these opportunities to drive growth,” says Dr Wong.

Dr Wong was the Executive Director of Malaysian fertility treatment chain TMC Life Sciences Bhd, as well as President of Thomson International, the international arm of obstetric and gynaecology hospital services provider Thomson Medical Centre.

His previous appointments include leadership positions in Pantai Holdings Berhad, Changi General Hospital, Singapore General Hospital, and SingHealth.

He was also the President of the Singapore Medical Association from 2006 to 2009, and an elected council member of the Academy of Medicine Singapore since 2009.

“He has a strong background as a medical professional and an established network in the regional and local healthcare industry as well as a track record in business development and corporate mergers and acquisitions which we believe will be of great value to the team,” says Dr Ho Choon Hou, Cordlife’s Chairman and Non-executive Director.

“We look forward to working closely with him and are confident that he can contribute to Cordlife’s long term growth,” he adds.

Cordlife shares closed 2.63% lower at S$1.30.